Study of Abiraterone Acetate, Atezolizumab, Lupron, and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Condition:   Metastatic Prostate Cancer Interventions:   Drug: Atezolizumab;   Drug: Abiraterone;   Drug: Prednisone;   Drug: Lupron Sponsors:   Memorial Sloan Kettering Cancer Center;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials